← All indications
Pulmonary Edema
Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.
Drugs by status
Approved for this indication (3)
Phase 4 trials (5)
Phase 3 trials (2)
Phase 2 trials (7)
Phase 1 trials (1)
Other trials (6)
Organizations
Organization Involved with Phase 4 Indications (9)
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (14)
- PhaseBio Pharmaceuticals Inc.
- Synvista Therapeutics, Inc
- Duke University
- Indiana University
- University of Tehran
- Wake Forest University
- University of Zurich
- University of California, San Francisco
- Vanderbilt University
- Medical University of South Carolina
- Department of Defense
- University of Minnesota
- Isfahan University
- California Transplant Donor Network
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (6)